- 1Department of Gynecologic Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- 2Cervical Cancer Control Center of Hubei Province. Maternal and Child Health Hospital of Hubei Province, Wuhan, China
A Correction on
CIN coexisting with AIS is a risk factor for residual disease after conization for cervical adenocarcinoma in situ
By Zeng R, Guo Y, Zou M, Wang C and Wu X (2025). Front. Oncol. 15:1571130. doi: 10.3389/fonc.2025.1571130
In the published article, there was an error in Affiliation 1. Instead of “Department of Gynecologic Oncology, Hubei Cancer Hospital, Wuhan, China”, it should be “Department of Gynecologic Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China”.
The original version of this article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: AIS, AIS-plus-CIN, hysterectomy, residual disease, conization, negative margin
Citation: Zeng R, Guo Y, Zou M, Wang C and Wu X (2025) Correction: CIN coexisting with AIS is a risk factor for residual disease after conization for cervical adenocarcinoma in situ. Front. Oncol. 15:1649631. doi: 10.3389/fonc.2025.1649631
Received: 18 June 2025; Accepted: 30 June 2025;
Published: 18 July 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Zeng, Guo, Zou, Wang and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xufeng Wu, end1eHVmZW5nQDE2My5jb20=